349 related articles for article (PubMed ID: 37383234)
1. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
[TBL] [Abstract][Full Text] [Related]
2. TREM2
Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
[TBL] [Abstract][Full Text] [Related]
3. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
5. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
6. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.
Stamm H; Klingler F; Grossjohann EM; Muschhammer J; Vettorazzi E; Heuser M; Mock U; Thol F; Vohwinkel G; Latuske E; Bokemeyer C; Kischel R; Dos Santos C; Stienen S; Friedrich M; Lutteropp M; Nagorsen D; Wellbrock J; Fiedler W
Oncogene; 2018 Sep; 37(39):5269-5280. PubMed ID: 29855615
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
9. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
[TBL] [Abstract][Full Text] [Related]
10. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2
He W; Hu Y; Chen D; Li Y; Ye D; Zhao Q; Lin L; Shi X; Lu L; Yin Z; He X; Gao Y; Wu Y
Clin Transl Med; 2022 Apr; 12(4):e800. PubMed ID: 35390227
[TBL] [Abstract][Full Text] [Related]
12. PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8
Whelan S; Ophir E; Kotturi MF; Levy O; Ganguly S; Leung L; Vaknin I; Kumar S; Dassa L; Hansen K; Bernados D; Murter B; Soni A; Taube JM; Fader AN; Wang TL; Shih IM; White M; Pardoll DM; Liang SC
Cancer Immunol Res; 2019 Feb; 7(2):257-268. PubMed ID: 30659054
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.
Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW
Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544
[No Abstract] [Full Text] [Related]
14. Bulk and single-cell transcriptome reveal the immuno-prognostic subtypes and tumour microenvironment heterogeneity in HCC.
Ji D; Lu S; Zhang H; Li Z; Wang S; Miao T; Jiang Z; Ao L
Liver Int; 2024 Apr; 44(4):979-995. PubMed ID: 38293784
[TBL] [Abstract][Full Text] [Related]
15. Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma.
Bahcivanci B; Shafiha R; Gkoutos GV; Acharjee A
Cancer Med; 2023 Jan; 12(1):696-711. PubMed ID: 35715992
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
[TBL] [Abstract][Full Text] [Related]
17. Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.
Xiong Z; Chan SL; Zhou J; Vong JSL; Kwong TT; Zeng X; Wu H; Cao J; Tu Y; Feng Y; Yang W; Wong PP; Si-Tou WW; Liu X; Wang J; Tang W; Liang Z; Lu J; Li KM; Low JT; Chan MW; Leung HHW; Chan AWH; To KF; Yip KY; Lo YMD; Sung JJ; Cheng AS
Gut; 2023 Sep; 72(9):1758-1773. PubMed ID: 37019619
[TBL] [Abstract][Full Text] [Related]
18. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
[TBL] [Abstract][Full Text] [Related]
19. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.
Sun R; Zhang Z; Bao R; Guo X; Gu Y; Yang W; Wei J; Chen X; Tong L; Meng J; Zhong C; Zhang C; Zhang J; Sun Y; Ling C; Tong X; Yu FX; Yu H; Qu W; Zhao B; Guo W; Qian M; Saiyin H; Liu Y; Liu RH; Xie C; Liu W; Xiong Y; Guan KL; Shi Y; Wang P; Ye D
J Hepatol; 2022 Aug; 77(2):453-466. PubMed ID: 35292350
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]